Results for: Quiz 1z0-076 - Oracle Database 19c: Data Guard Administration Marvelous Reliable Exam Sample 🔡 Download ▷ 1z0-076 ◁ for free by simply searching on “ www.pdfvce.com ” 😙1z0-076 Valid Test Tips

AAN 2023 HIGHLIGHTS – WEDNESDAY, APRIL 26

…fying therapy. Data were collected in the period 2008 to 2022 and aquaporin-4 (AQP4-IgG) antibody testing may not have been available or routinely used during part of the observation period. sNfL after menopause Serum neurofilament-light chain levels appear to increase after menopause, according to a UCSF longitudinal study of 186 postmenopausal women with MS (Silverman et al. AAN 2023; S9.009). Median age at menopause was 52 years; median duratio…

AAN 2023 HIGHLIGHTS – TUESDAY, APRIL 25

…;P1.011). Lower NfL levels were associated with better MRI and clinical outcomes. Comparing BTK inhibitors: A pharmacologic study compared the effects of three BTK inhibitors (tolebrutinib, evobrutinib, fenebrutinib) in the CNS in non-human primates (Turner et al. AAN 2023;S46.007). The three drugs achieved similar levels in the CSF after a single oral dose. However, only tolebrutinib CSF exposure exceeded the 90% inhibitory concentration (IC90);…

AAN 2023 HIGHLIGHTS – MONDAY, APRIL 24

…ed in 2020/2021 vs. 26-30% pre-pandemic (https://www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm). The same does not appear to be the case for JC virus transmission. An analysis of the TOUCH database (N=22,375) found that during the period of masking and social distancing (2020 to 2022), anti-JCV antibody serostatus changed in about 7.2% of Tysabri patients (Krieger et al. AAN 2023;P12.007). This was comparable to the rate seen prior to the pa…

Is vitamin D supplementation justified?

…followed. The phase II SOLAR study randomized patients receiving interferon-beta-1a 44 mcg to high-dose supplementation (14,000 IU/day) or placebo (Hupperts et al. Neurology 2019;93:e1906-e1916). There was no benefit of add-on vitamin D with respect to the primary outcome (NEDA-3), but exploratory outcomes (combined unique active lesions, T2 lesion volume) suggested some effect. Similarly, in the CHOLINE trial, high-dose vitamin D (100,000 IU ever…

Putting biomarkers into practice

…al NfL measures in individual patients (see RCV tool at BMJ 2020;368:m149: www.bmj.com/content/368/bmj.m149/rr-8). Serum NfL was obtained every three months in 58 MS patients over one year. In comparing patients with and without MRI lesions, median RCV was 57 and 92, respectively. An RCV using a cut-off of >76 was predictive of new MRI lesions (sensitivity 60%, specificity 75%). A 10-unit increase in RCV was associated with a 30% increase in the o…